Market Research Report

Emerging Infectious Disease Market, Global Outlook and Forecast 2023-2029

  • AMR ID : 7-1111
  • CAT ID : 7
  • Pages : 94
  • Date : May 2023
 

The global Emerging Infectious Disease market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
AIDS Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Emerging Infectious Disease include BD, Abbott, BioMerieux, Danaher, Orasure, Qiagen, Quidel, Sysmex and Gen-Probe, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Emerging infectious diseases can be defined as infectious diseases that have newly appeared in a population or have existed but are rapidly increasing in incidence or geographic range, or that are caused by one of the NIAID Category A, B, or C priority pathogens.
This report aims to provide a comprehensive presentation of the global market for Emerging Infectious Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Emerging Infectious Disease. This report contains market size and forecasts of Emerging Infectious Disease in global, including the following market information:
Global Emerging Infectious Disease Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Emerging Infectious Disease companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Emerging Infectious Disease Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Emerging Infectious Disease Market Segment Percentages, by Type, 2022 (%)
AIDS
Ebola
SARS
Avian Flu
Chikungunya
Zika
Others
Global Emerging Infectious Disease Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Emerging Infectious Disease Market Segment Percentages, by Application, 2022 (%)
Clinical Laboratories
Diagnostic Centers
Others
Global Emerging Infectious Disease Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Emerging Infectious Disease Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Emerging Infectious Disease revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Emerging Infectious Disease revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD
Abbott
BioMerieux
Danaher
Orasure
Qiagen
Quidel
Sysmex
Gen-Probe
Cepheid
Hologic
Outline of Major Chapters:
Chapter 1: Introduces the definition of Emerging Infectious Disease, market overview.
Chapter 2: Global Emerging Infectious Disease market size in revenue.
Chapter 3: Detailed analysis of Emerging Infectious Disease company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Emerging Infectious Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
1.1 Emerging Infectious Disease Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Emerging Infectious Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Emerging Infectious Disease Overall Market Size
2.1 Global Emerging Infectious Disease Market Size: 2022 VS 2029
2.2 Global Emerging Infectious Disease Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Emerging Infectious Disease Players in Global Market
3.2 Top Global Emerging Infectious Disease Companies Ranked by Revenue
3.3 Global Emerging Infectious Disease Revenue by Companies
3.4 Top 3 and Top 5 Emerging Infectious Disease Companies in Global Market, by Revenue in 2022
3.5 Global Companies Emerging Infectious Disease Product Type
3.6 Tier 1, Tier 2 and Tier 3 Emerging Infectious Disease Players in Global Market
3.6.1 List of Global Tier 1 Emerging Infectious Disease Companies
3.6.2 List of Global Tier 2 and Tier 3 Emerging Infectious Disease Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Emerging Infectious Disease Market Size Markets, 2022 & 2029
4.1.2 AIDS
4.1.3 Ebola
4.1.4 SARS
4.1.5 Avian Flu
4.1.6 Chikungunya
4.1.7 Zika
4.1.8 Others
4.2 By Type - Global Emerging Infectious Disease Revenue & Forecasts
4.2.1 By Type - Global Emerging Infectious Disease Revenue, 2018-2023
4.2.2 By Type - Global Emerging Infectious Disease Revenue, 2024-2029
4.2.3 By Type - Global Emerging Infectious Disease Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Emerging Infectious Disease Market Size, 2022 & 2029
5.1.2 Clinical Laboratories
5.1.3 Diagnostic Centers
5.1.4 Others
5.2 By Application - Global Emerging Infectious Disease Revenue & Forecasts
5.2.1 By Application - Global Emerging Infectious Disease Revenue, 2018-2023
5.2.2 By Application - Global Emerging Infectious Disease Revenue, 2024-2029
5.2.3 By Application - Global Emerging Infectious Disease Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Emerging Infectious Disease Market Size, 2022 & 2029
6.2 By Region - Global Emerging Infectious Disease Revenue & Forecasts
6.2.1 By Region - Global Emerging Infectious Disease Revenue, 2018-2023
6.2.2 By Region - Global Emerging Infectious Disease Revenue, 2024-2029
6.2.3 By Region - Global Emerging Infectious Disease Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Emerging Infectious Disease Revenue, 2018-2029
6.3.2 US Emerging Infectious Disease Market Size, 2018-2029
6.3.3 Canada Emerging Infectious Disease Market Size, 2018-2029
6.3.4 Mexico Emerging Infectious Disease Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Emerging Infectious Disease Revenue, 2018-2029
6.4.2 Germany Emerging Infectious Disease Market Size, 2018-2029
6.4.3 France Emerging Infectious Disease Market Size, 2018-2029
6.4.4 U.K. Emerging Infectious Disease Market Size, 2018-2029
6.4.5 Italy Emerging Infectious Disease Market Size, 2018-2029
6.4.6 Russia Emerging Infectious Disease Market Size, 2018-2029
6.4.7 Nordic Countries Emerging Infectious Disease Market Size, 2018-2029
6.4.8 Benelux Emerging Infectious Disease Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Emerging Infectious Disease Revenue, 2018-2029
6.5.2 China Emerging Infectious Disease Market Size, 2018-2029
6.5.3 Japan Emerging Infectious Disease Market Size, 2018-2029
6.5.4 South Korea Emerging Infectious Disease Market Size, 2018-2029
6.5.5 Southeast Asia Emerging Infectious Disease Market Size, 2018-2029
6.5.6 India Emerging Infectious Disease Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Emerging Infectious Disease Revenue, 2018-2029
6.6.2 Brazil Emerging Infectious Disease Market Size, 2018-2029
6.6.3 Argentina Emerging Infectious Disease Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Emerging Infectious Disease Revenue, 2018-2029
6.7.2 Turkey Emerging Infectious Disease Market Size, 2018-2029
6.7.3 Israel Emerging Infectious Disease Market Size, 2018-2029
6.7.4 Saudi Arabia Emerging Infectious Disease Market Size, 2018-2029
6.7.5 UAE Emerging Infectious Disease Market Size, 2018-2029
7 Emerging Infectious Disease Companies Profiles
7.1 BD
7.1.1 BD Company Summary
7.1.2 BD Business Overview
7.1.3 BD Emerging Infectious Disease Major Product Offerings
7.1.4 BD Emerging Infectious Disease Revenue in Global Market (2018-2023)
7.1.5 BD Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Emerging Infectious Disease Major Product Offerings
7.2.4 Abbott Emerging Infectious Disease Revenue in Global Market (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 BioMerieux
7.3.1 BioMerieux Company Summary
7.3.2 BioMerieux Business Overview
7.3.3 BioMerieux Emerging Infectious Disease Major Product Offerings
7.3.4 BioMerieux Emerging Infectious Disease Revenue in Global Market (2018-2023)
7.3.5 BioMerieux Key News & Latest Developments
7.4 Danaher
7.4.1 Danaher Company Summary
7.4.2 Danaher Business Overview
7.4.3 Danaher Emerging Infectious Disease Major Product Offerings
7.4.4 Danaher Emerging Infectious Disease Revenue in Global Market (2018-2023)
7.4.5 Danaher Key News & Latest Developments
7.5 Orasure
7.5.1 Orasure Company Summary
7.5.2 Orasure Business Overview
7.5.3 Orasure Emerging Infectious Disease Major Product Offerings
7.5.4 Orasure Emerging Infectious Disease Revenue in Global Market (2018-2023)
7.5.5 Orasure Key News & Latest Developments
7.6 Qiagen
7.6.1 Qiagen Company Summary
7.6.2 Qiagen Business Overview
7.6.3 Qiagen Emerging Infectious Disease Major Product Offerings
7.6.4 Qiagen Emerging Infectious Disease Revenue in Global Market (2018-2023)
7.6.5 Qiagen Key News & Latest Developments
7.7 Quidel
7.7.1 Quidel Company Summary
7.7.2 Quidel Business Overview
7.7.3 Quidel Emerging Infectious Disease Major Product Offerings
7.7.4 Quidel Emerging Infectious Disease Revenue in Global Market (2018-2023)
7.7.5 Quidel Key News & Latest Developments
7.8 Sysmex
7.8.1 Sysmex Company Summary
7.8.2 Sysmex Business Overview
7.8.3 Sysmex Emerging Infectious Disease Major Product Offerings
7.8.4 Sysmex Emerging Infectious Disease Revenue in Global Market (2018-2023)
7.8.5 Sysmex Key News & Latest Developments
7.9 Gen-Probe
7.9.1 Gen-Probe Company Summary
7.9.2 Gen-Probe Business Overview
7.9.3 Gen-Probe Emerging Infectious Disease Major Product Offerings
7.9.4 Gen-Probe Emerging Infectious Disease Revenue in Global Market (2018-2023)
7.9.5 Gen-Probe Key News & Latest Developments
7.10 Cepheid
7.10.1 Cepheid Company Summary
7.10.2 Cepheid Business Overview
7.10.3 Cepheid Emerging Infectious Disease Major Product Offerings
7.10.4 Cepheid Emerging Infectious Disease Revenue in Global Market (2018-2023)
7.10.5 Cepheid Key News & Latest Developments
7.11 Hologic
7.11.1 Hologic Company Summary
7.11.2 Hologic Business Overview
7.11.3 Hologic Emerging Infectious Disease Major Product Offerings
7.11.4 Hologic Emerging Infectious Disease Revenue in Global Market (2018-2023)
7.11.5 Hologic Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

 
Choose License Type

Single User : $3250


Corporate User : $4225


Why Choose Us ?

24/7 Research support

Quality assurance

Information security

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe